InnovAge Reports 15.5% Revenue Growth but Incurred $29.1 Million Operating Loss in Latest Quarter

InnovAge Holding Corp. reported its financial results for the quarter ending March 31, 2026, revealing a total revenue of $251.9 million, a 15.5% increase from $218.1 million in the same period last year. The growth was primarily driven by a 15.5% rise in capitation revenue, which reached $251.5 million, attributed to an increase in capitation rates and member months. For the nine months ending March 31, 2026, total revenue was $727.8 million, up 15.1% from $632.3 million in the prior year, with capitation revenue contributing $726.9 million.

Despite the revenue growth, InnovAge reported an operating loss of $29.1 million for the quarter, compared to a loss of $10.2 million in the same quarter of the previous year. The increase in losses was largely due to a significant rise in corporate, general, and administrative expenses, which surged by 98.3% to $76.5 million, driven by litigation costs and organizational restructuring. Total expenses for the quarter were $281 million, up from $228.3 million a year earlier. The net loss attributable to InnovAge Holding Corp. was $29.5 million, or $0.22 per share, compared to a loss of $11.4 million, or $0.08 per share, in the prior year.

Operationally, InnovAge served approximately 8,050 PACE participants across 20 centers in six states, marking an increase in customer count from 7,530 participants a year earlier. The company reported a total of 71,530 member months for the nine months ending March 31, 2026, compared to 66,130 in the same period last year. The Center-level Contribution Margin, a key performance metric, increased to $165.2 million, representing 22.7% of revenue, up from 17.8% in the previous year.

Strategically, InnovAge has focused on expanding its footprint through joint ventures, including partnerships with Orlando Health and Tampa General Hospital to develop new PACE centers in Florida. However, the company faces challenges, including increased costs of care and external provider costs, driven by labor shortages and inflationary pressures. The ongoing impact of the One Big Beautiful Bill Act (OBBBA) and state Medicaid budget constraints may also affect future revenue and operational capacity.

Looking ahead, InnovAge anticipates continued growth in capitation revenue and participant enrollment, although it remains cautious about potential regulatory changes and market conditions that could impact its operations. The company plans to invest in its centers and operational efficiencies to manage costs while navigating the complexities of the healthcare landscape.